One of the most frequently observed molecular aberrations involving MET is gene amplification, exhibiting a prevalence rate of approximately 4% across various tumor types, as illustrated in Figure 3A and corroborated by multiple studies [52,53,54,55,56,57]. Here, MET is linked to neoplasm.